Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
作者信息
Harenberg J, Zimmermann R, Schwarz F, Kübler W
出版信息
Lancet. 1983 Apr 30;1(8331):986-7. doi: 10.1016/s0140-6736(83)92107-4.
PMID:6132291
Abstract
摘要
相似文献
1
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.新型类肝素治疗肝素诱导的血小板减少症伴血栓形成。
Lancet. 1983 Apr 30;1(8331):986-7. doi: 10.1016/s0140-6736(83)92107-4.
2
The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.低分子量类肝素（Org 10172）在肝素依赖型血小板减少症和血栓形成患者体外操作中的应用。
Aust N Z J Med. 1991 Feb;21(1):52-4. doi: 10.1111/j.1445-5994.1991.tb03003.x.
3
Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Aust N Z J Med. 1986 Oct;16(5):719. doi: 10.1111/j.1445-5994.1986.tb00027.x.
4
Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Intensive Care Med. 1991;17(7):437. doi: 10.1007/BF01720689.
5
Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery.
Circulation. 2011 Mar 29;123(12):1355-7. doi: 10.1161/CIRCULATIONAHA.110.966523.
6
7
In vivo activity of a new heparinoid.一种新型类肝素的体内活性
Pathology. 1985 Jan;17(1):78-81. doi: 10.3109/00313028509063731.
8
Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
Thromb Res. 1991 Apr;62(1-2):23-9. doi: 10.1016/0049-3848(91)90665-j.
9
Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
Ann Hematol. 1992 Jan;64(1):40-2. doi: 10.1007/BF01811470.
10
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.肝素诱导的血小板减少症和动脉血栓形成：替代疗法。
Am Heart J. 1990 Feb;119(2 Pt 1):368-74. doi: 10.1016/s0002-8703(05)80029-8.
引用本文的文献
1
Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.达那肝素可降低造血干细胞移植相关血栓性微血管病的发生率。
Bone Marrow Transplant. 2017 Feb;52(2):307-309. doi: 10.1038/bmt.2016.270. Epub 2016 Nov 28.
2
Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.普通肝素与低分子肝素类似物对血小板功能影响的比较。
Br J Clin Pharmacol. 1984 Jan;17(1):43-8. doi: 10.1111/j.1365-2125.1984.tb04997.x.
3
[Ambulatory long-term prevention of thromboembolism with low-molecular weight heparin].
Klin Wochenschr. 1987 Apr 1;65(7):331-7. doi: 10.1007/BF01745389.
4
Anticoagulants.抗凝剂。
Br Med J (Clin Res Ed). 1987 Feb 14;294(6569):428-30. doi: 10.1136/bmj.294.6569.428.
5
Heparin-induced thrombocytopenia.肝素诱导的血小板减少症。
Blut. 1989 Feb;58(2):53-7. doi: 10.1007/BF00320647.
6
Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.给予健康老年志愿者低分子量类肝素Org 10172的安全性和药代动力学。
Br J Clin Pharmacol. 1989 Jan;27(1):39-48. doi: 10.1111/j.1365-2125.1989.tb05333.x.
Zotero 插件